Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Sep 6;10(25):9142-9147.
doi: 10.12998/wjcc.v10.i25.9142.

Tamsulosin-induced life-threatening hypotension in a patient with spinal cord injury: A case report

Affiliations
Case Reports

Tamsulosin-induced life-threatening hypotension in a patient with spinal cord injury: A case report

Jae Young Lee et al. World J Clin Cases. .

Abstract

Background: Tamsulosin, a selective α1-adrenergic receptor antagonist, is commonly used for treating neurogenic bladder in patients with spinal cord injury (SCI). No severe adverse events have been described with such tamsulosin use. To our knowledge, we report the first case of severe life-threatening hypotension as an adverse effect of tamsulosin in a person with SCI. Therefore, we report this case to inform that this severe adverse effect of tamsulosin can occur when treating patients with SCI.

Case summary: A 59-year-old woman was diagnosed with cervical spinal cord myelopathy and was classified as American Spinal Injury Association Impairment Scale D, neurological level of injury C3. Because she suffered from voiding difficulty due to neurogenic bladder, we prescribed tamsulosin. Her vital signs remained stable, but occasional hypotensive symptoms followed defecation. We reduced the dose of tamsulosin, but after administering tamsulosin for 9 d, she experienced life-threatening hypotension with no evidence of hypovolemic shock, neurogenic shock, cardiogenic shock, or septic shock. A hypotensive condition induced by tamsulosin was the suspected cause, and her symptoms could be associated with adverse effects of tamsulosin. As symptoms resolved after stopping tamsulosin, and no other reason was found, we concluded that tamsulosin was the cause of her symptoms.

Conclusion: Caution for severe hypotension is needed when administering tamsulosin for neurogenic bladder in a patient with SCI.

Keywords: Case report; Hypotension; Neurogenic bladder; Spinal cord injury; Tamsulosin; Vasovagal symptoms.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Figures

Figure 1
Figure 1
Cervical spine magnetic resonance imaging findings at admission. A: T2 sagittal image. Cord signal changes at C4-C6 levels were observed; B: T2 axial image at C4 level. Cord signal changes at C4 level are shown; C: T2 axial image at C5 level. Cord signal changes at C5 level and possible hematoma were observed; D: T2 axial image at C6 level. Cord signal changes at C6 level are shown.
Figure 2
Figure 2
Chest X-ray at the first hypotensive event. No specific findings were revealed at the event.

Similar articles

Cited by

References

    1. Chapple C, Andersson KE. Tamsulosin: an overview. World J Urol. 2002;19:397–404. - PubMed
    1. Michel MC, Bressel HU, Goepel M, Rübben H. A 6-month large-scale study into the safety of tamsulosin. Br J Clin Pharmacol. 2001;51:609–614. - PMC - PubMed
    1. Abrams P, Amarenco G, Bakke A, Buczyński A, Castro-Diaz D, Harrison S, Kramer G, Marsik R, Prajsner A, Stöhrer M, Van Kerrebroeck P, Wyndaele JJ European Tamsulosin Neurogenic Lower Urinary Tract Dysfunction Study Group. Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury. J Urol. 2003;170:1242–1251. - PubMed
    1. Meyer LE, Brown JN. Tamsulosin for voiding dysfunction in women. Int Urol Nephrol. 2012;44:1649–1656. - PubMed
    1. Zhang HL, Huang ZG, Qiu Y, Cheng X, Zou XQ, Liu TT. Tamsulosin for treatment of lower urinary tract symptoms in women: a systematic review and meta-analysis. Int J Impot Res. 2017;29:148–156. - PubMed

Publication types